Smith & Nephew PLC (OTC Pink - Current Information:SNNUF)
| 14.80 Delayed Data As of Jun 07 |  -0.23 / -1.53%Today’s Change | 10.76 Today|||52-Week Range 16.74 | +10.86% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $13.6B |
Company Description
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Contact Information
Smith & Nephew plc Croxley Park Watford Herefordshire WD18 8YE |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Deepak S Nath | Chief Executive Officer & Director |
| Paul Connolly | President-Global Operations |
| Anne-Francoise Nesmes | Chief Financial Officer & Executive Director |
| Alison Parkes | Chief Compliance Officer |
| Philip G. Cowdy | Chief Business Development Officer |
